Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2026)

Elanco Animal Health has disclosed Cash from Financing Activities across 10 years of filings, most recently posting -$74.0 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 52.56% year-over-year to -$74.0 million; the TTM figure through Jun 2026 stood at -$310.0 million (up 79.0% YoY), while the FY2025 annual figure was -$275.0 million, up 81.57% from the prior year.
• Cash from Financing Activities came in at -$74.0 million for Q2 2026 at Elanco Animal Health, down from -$65.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $174.0 million in Q1 2023 to a low of -$1.3 billion in Q3 2024.
• Average Cash from Financing Activities over 5 years is -$141.0 million, with a median of -$88.5 million recorded in 2022.
• Year-over-year, Cash from Financing Activities sank 10100.0% in 2022 and jumped 292.59% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$84.0 million in 2022, then tumbled by 65.48% to -$139.0 million in 2023, then surged by 76.98% to -$32.0 million in 2024, then surged by 43.75% to -$18.0 million in 2025, then plunged by 311.11% to -$74.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$74.0 million in Q2 2026, -$65.0 million in Q1 2026, and -$18.0 million in Q4 2025.